Picture of Image Scan Holdings logo

IGE Image Scan Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

REG - Image Scan Holdings - Half Yearly Report <Origin Href="QuoteRef">IMGE.L</Origin>

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140612:nRSL4018Ja


RNS Number : 4018J
Image Scan Holdings PLC
12 June 2014 
 
Image Scan Holdings plc 
 
Interim report 2014 
 
12 June 2014 
 
IMAGE SCAN HOLDINGS PLC 
 
("Image Scan" or the "Company") 
 
(AIM: IGE) 
 
INTERIM RESULTS 
 
Revenue up 57%, reduced overheads 
 
Image Scan, the AIM-listed specialist supplier of x-ray screening systems to
the security and industrial inspection markets, today announces its interim
results for the six months ended 31 March 2014. 
 
Financial summary: 
 
·      Revenue up 57% to £1,678,000 (2013: £1,072,000) 
 
·      Gross profit margin of 31% (2013: 32%) after provision for further
losses on the nuclear contract 
 
·      Overheads down 22% to £576,000 (2013: £740,000) following the 2013
restructuring exercise 
 
·      Loss after taxation of £36,000 (2013: £389,000) 
 
·      Period end bank balance of £25,000 (2013: £138,000) 
 
·      Current bank balance of £190,000 
 
Operational highlights: 
 
·      Board realigned and strengthened with appointment of Bill Mawer as
Chairman and Chief Executive Officer 
 
·      H1 revenue increase based on strong sales across whole security product
range 
 
·      Delivered a number of multiple unit contracts for the portable FlatScan
system 
 
·      Repeat sales of standard industrial systems to existing customer 
 
·      Confirmed orders of £2.3m having opened the year with £1.2m and booked
£1.1m of new orders in the year to date 
 
Bill Mawer, Chairman and Chief Executive Officer of Image Scan, commented:
"These results show positive improvement over the equivalent period in the
prior year, and the growth in sales in the core portable X-ray market is
particularly encouraging.  Maintenance of that growth is dependent, in the
short term, on the supply of a newly developed replacement portable x-ray
generator, and, in the medium term, on the timely completion of new product
development. 
 
"Image Scan has a strong brand in its core markets; however, there is a need
to accelerate product development in order to drive the business forward, both
in terms of the competitive solutions we provide and our geographical reach.
Our strategy will focus on supporting targeted growth in our R&D and sales
activity with the aim of evolving Image Scan into a business that consistently
delivers both top-line growth and bottom line profitability." 
 
For further information on the Company, please visit: www.ish.co.uk and for
further information on its products, please visit: www.3dx-ray.com 
 
 Enquiries:                                                                                                                            
 Image Scan Holdings plcBill Mawer, Chairman and Chief Executive Officer                        Tel: +44 (0) 1509 817 400ir@ish.co.uk  
 Cantor Fitzgerald Europe (Nominated Adviser)  Mark Percy/Rick ThompsonPaul Jewell/David Banks  Tel: +44 (0) 207 894 7000              
 Yellow Jersey PR LimitedDominic BarrettoAnna Legge                                             Tel: +44 (0) 7768 537 739              
 
 
Chairman's statement 
 
Introduction 
 
I am pleased to report my first set of results as Chairman and Chief Executive
Officer of Image Scan.  Image Scan remains focused on the development and
commercialisation of market leading real-time x-ray solutions for use in the
global security and industrial inspection markets.  The Company's Security
portfolio includes the Axis range of conveyor systems; the FlatScan range of
portable bomb and suspect package detection systems; and SVXi, a small vehicle
inspection system.  The Industrial Inspection solutions include the MDXi
product range, cabinet x-ray systems for laboratories and production lines. 
 
Financial results 
 
I am pleased to report that revenue for the six months has increased by 57% to
£1,678,000 (2013: £1,072,000) based on strong sales across the whole security
product portfolio.  The gross margin of 31% (2013: 32%) reflected two
significant security contracts which were subject to highly competitive
tendering processes and the recognition of a further £30,000 (2013: £112,000)
of losses against the nuclear contract. 
 
Following the restructuring exercise carried out in May 2013, the comparative
overheads for the period were down by 22% to £576,000 (2013: £740,000).  As a
result, the Company has made a loss after tax of £36,000 (2013: £389,000). 
The loss per share was 0.05p (2013: 0.5p). 
 
The cash position as at the end of the period was £25,000 (2013: £138,000). 
The Company has an agreed £100,000 overdraft facility with the Royal Bank of
Scotland.  The current bank balance is £190,000. 
 
Overview 
 
Security accounted for 85% of total sales.  Security revenue in the period was
£1,427,000 (2013: £546,000) with increased levels of sales reported against
each of the conveyor, portable and vehicle screening product ranges.  First
half sales of both the conveyor and portable products included a number of
multiple unit contracts. 
 
Industrial revenue of £251,000 (2013: £526,000) comprised 15% of total revenue
and included the sale of a cabinet x-ray system to an existing customer and
further deliverables on the nuclear contract.  The nuclear customer has
accepted delivery of the system and the final phases relate to installation,
commissioning and training at the customer's site.  Key software engineering
resources previously engaged on this contract have now been refocused on the
development of the core product range. 
 
Subsequent to the period end, the following Board appointments were made to
strengthen the technology lead and provide greater strategic focus: 
 
o  Bill Mawer, as Chairman and Chief Executive Officer, who has 13 years'
experience with Smiths Detection and is a specialist in product development
and market strategy; and 
 
o  Dr Richard Leaver, as Non-Executive Director, who has extensive
international experience of developing and sustaining value in technology-rich
growth businesses at all stages of investment. 
 
Outlook 
 
The Company has total confirmed orders in the year to date of £2.3m, having
started the year with an opening order book of £1.2m and secured new orders of
£1.1m.  All outstanding orders are deliverable in the current financial year. 
Whilst the revenue in the first half of the year was on target, performance in
the second half will be reliant on the supply of a newly developed portable
generator to replace the existing system which is no longer available. 
 
As a result of the commitment of a limited resource base to the nuclear
contract over the last three years the Company's R&D activities have been
restricted to modest incremental development.  The Board recognises the need
to expand the product range and has been reviewing what additional inputs are
required to accelerate product development.  The strategy that I have been
developing since becoming involved with the Company in late 2013 will be to
support carefully targeted growth in R&D and sales activity to include the
following projects: 
 
o  complete the renewal of the existing portable x-ray product range to
restore its competitive edge; 
 
o  extend the portable range to include both higher and lower-end solutions,
giving the Company, for the first time, a competitive product in each market
segment; 
 
o  co-development, with an experienced partner, of a highly competitive range
of checkpoint x-ray systems to replace the current Axis products; 
 
o  recruit an additional security sales manager and development of the sales
network to provide geographical coverage of all important security x-ray
markets; and 
 
o  recruit a dedicated sales manager for industrial sales, in order to expand
the Company's potentially valuable market position. 
 
Image Scan has a strong brand in its core markets and loyal distributors and
customers. Over-commitment of its limited R&D resources in recent years has
caused a decline in competitiveness which is now being addressed. The staff at
Image Scan are enthusiastic, dedicated and creative and on behalf of my fellow
Board members and shareholders, I would like to formally thank our staff for
their contribution during this period. 
 
Bill Mawer 
 
Chairman and Chief Executive Officer 
 
12 June 2014 
 
Consolidated income statement 
 
for the six months ended 31 March 2014 
 
                                Six months ended  Six months ended          Year ended         
                                31 March 2014     31 March 2013             30 September 2013  
                                (Unaudited)       (Unaudited and restated)  (Audited)          
                          Note  £'000             £'000                     £'000              
 Revenue                        1,678             1,072                     2,538              
 Cost of sales            2     (1,161)           (731)                     (1,587)            
 Gross profit                   517               341                       951                
 Administrative expenses  2     (576)             (740)                     (1,293)            
 Operating loss                 (59)              (399)                     (342)              
 Finance revenue                -                 -                         -                  
 Loss before taxation           (59)              (399)                     (342)              
 Taxation                       23                10                        45                 
 Loss for the period            (36)              (389)                     (297)              
 
 
                                      Pence   Pence   Pence   
 Earnings per share                                           
 Basic and diluted loss per share  4  (0.05)  (0.50)  (0.39)  
 
 
Consolidated statement of changes in equity 
 
for the six months ended 31 March 2014 
 
                                                 Six months to  Six months to  Year to            
                                                 31 March 2014  31 March 2013  30 September 2013  
                                                 (Unaudited)    (Unaudited)    (Audited)          
                                           Note  £'000          £'000          £'000              
 Opening equity shareholders' funds              677            977            977                
 Share-based payments                      5     -              -              (3)                
 Loss attributable to equity shareholders        (36)           (390)          (297)              
                                                 641            587            677                
 
 
Consolidated balance sheet 
 
as at 31 March 2014 
 
                                         As at          As at          As at              
                                         31 March 2014  31 March 2013  30 September 2013  
                                         (Unaudited)    (Unaudited)    (Audited)          
                                         £'000          £'000          £'000              
 Non-current assets                                                                       
 Plant and equipment                     16             31             22                 
 Intangible assets                       -              -              -                  
                                         16             31             22                 
 Current assets                                                                           
 Inventories                             352            650            458                
 Trade and other receivables             651            240            1,120              
 Cash and cash equivalents               25             138            12                 
 Current tax asset                       59             -              36                 
                                         1,087          1,028          1,626              
 Total assets                            1,103          1,059          1,648              
 Current liabilities                                                                      
 Trade and other payables                440            426            928                
 Non-current liabilities                                                                  
 Provisions for liabilities and charges  22             46             43                 
 Total liabilities                       462            472            971                
 Net assets                              641            587            677                
 Equity                                                                                   
 Share capital                           763            763            763                
 Share premium account                   7,501          7,501          7,501              
 Retained earnings                       (7,623)        (7,677)        (7,587)            
 Equity shareholders' funds              641            587            677                
 
 
This interim financial information was approved by the Board of Directors on
12 June 2014. 
 
Bill Mawer 
 
Chairman and Chief Executive Officer 
 
Consolidated cash flow statement 
 
for the six months ended 31 March 2014 
 
                                                       Six months to  Six months to  Year to            
                                                       31 March 2014  31 March 2013  30 September 2013  
                                                       (Unaudited)    (Unaudited)    (Audited)          
                                                       £'000          £'000          £'000              
 Cash flows from operating activities                                                                   
 Operating loss                                        (59)           (400)          (342)              
 Adjustments for:                                                                                       
 Depreciation                                          7              11             21                 
 Transfer of fixed assets to stock                     2              -              4                  
 Decrease/(increase) in inventories                    106            (237)          (46)               
 Decrease in trade and other receivables               469            548            2                  
 (Decrease)/increase in trade and other payables       (509)          60             224                
 Share-based payment charge                            -              -              (2)                
 Corporation tax recovered                             -              85             85                 
 Net cash inflow/(outflow) from operating activities   16             67             (54)               
 Cash flows from investing activities                                                                   
 Purchase of property, plant and equipment             (3)            (3)            (8)                
 Net cash used in investing activities                 (3)            (3)            (8)                
 Net increase/(decrease) in cash and cash equivalents  13             64             (62)               
 Cash and cash equivalents at beginning of period      12             74             74                 
 Cash and cash equivalents at end of period            25             138            12                 
 
 
Notes to the unaudited interim financial statements 
 
for the six months ended 31 March 2014 
 
1 Basis of preparation 
 
The interim financial statements, which are unaudited, have been prepared on
the basis of the accounting policies expected to apply for the financial year
to 30 September 2014 and in accordance with recognition and measurement
principles of International Financial Reporting Standards (IFRSs) as endorsed
by the European Union.  The accounting policies applied in the preparation of
these interim financial statements are consistent with those used in the
financial statements for the year ended 30 September 2013. 
 
The interim financial statements do not include all of the information
required for full annual financial statements and do not comply with all the
disclosures in IAS 34 'Interim Financial Reporting'. Accordingly, whilst the
interim statements have been prepared in accordance with IFRS, they cannot be
construed as being in full compliance with IFRSs. 
 
The financial information for the year ended 30 September 2013 does not
constitute the full statutory accounts for that period. The Annual Report and
Financial Statements for the year ended 30 September 2013 have been filed with
the Registrar of Companies. The independent Auditor's Report on the Report and
Financial Statements for the year ended 30 September 2013 was unqualified, did
not draw attention to any matters by way of emphasis, and did not contain a
statement under 498(2) or 498(3) of the Companies Act 2006. 
 
2 Losses on nuclear contract 
 
In the 2013 interim results, the loss of £112,000 on the nuclear contract was
reported as an exceptional item within administrative expenses.  This was
subsequently accounted for as cost of sales in the full statutory accounts for
the year ended 2013.  The comparative 2013 numbers in the 2014 interim results
reflect this same treatment, giving cost of sales of £731,000 and
administrative expenses of £740,000 (previously reported as £619,000 and
£852,000 respectively). 
 
3 Going concern 
 
The interim financial information has been prepared on a going concern basis,
which assumes that the Company will have adequate resources to continue in
operational existence for the foreseeable future. 
 
4 Earnings per share ('EPS') 
 
Basic earnings per ordinary share is based on the loss on ordinary activities
after taxation of £36,000 and on 76,267,932 ordinary shares in issue
throughout the period. 
 
IAS 33 requires presentation of diluted EPS when a company could be called
upon to issue shares that would decrease net profit or increase net loss per
share. Earnings or loss per share would not be affected by the exercise of
out-of-the-money options since it is inappropriate to assume that option
holders would act irrationally.  Accordingly as there are no other diluting
future share issues, diluted EPS equals basic EPS. 
 
5 IFRS 2 'Share-based payments' 
 
Operating expenses includes a charge of £nil (2013: £nil) after valuation of
the Company's employee share option schemes in accordance with IFRS 2. Under
this standard, the fair value of the options at the grant date is spread over
the vesting period. These items have been added back in the consolidated
statement of changes in equity. 
 
6 Additional copies 
 
Further copies of the 2014 interim report are available on the Company's
website, www.ish.co.uk, and from the Company's registered office, 16-18
Hayhill Industrial Estate, Sileby Road, Barrow-upon-Soar, Leicestershire LE12
8LD. 
 
This information is provided by RNS
The company news service from the London Stock Exchange

Recent news on Image Scan Holdings

See all news